← Leaderboards
J. McLeod Griffiss
Icon Government And Public Health Solutions, Inc.
$3,088,882
Attributed
$3,088,882
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2014–17$2M$1.5M$1M$500K$0
'14
'15
'16
'17
Funding mix
By agency
NIH$3,088,882 · 2
By mechanism
N01$2,596,029 · 2
N02$492,853 · 1
Top collaborators
No co-investigators on record.
Most similar at Icon Government And Public Health Solutions, Inc.
Same institution · by research overlap
- Robert Spitz$3,033,881
- Kristopher Paolino$4,299,774
- Robert Tibbetts$231,167
- Chris Mason$321,691
- J McLeod Griffiss$206,912
Others in their field
Top investigators on “Biological”
- David Heimbrook · Leidos Biomedical Research, Inc.$731,505,112
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Lawrence Corey · Fred Hutchinson Cancer Center$543,202,300
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$480,487,534
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
BiologicalClinical ResearchClinical Research SiteClinical TrialsClinical Trials Cooperative GroupLaboratory PersonnelLeadershipProtocol DevelopmentResearch InfrastructureSample CollectionSexually Transmitted DiseasesTrainingTherapeutic EvaluationTreatment StrategySafetyMulticenter StudiesNeisseria GonorrhoeaeNovel TherapeuticsPhase I Clinical TrialsPhase Iii Clinical TrialsInfectious Disease TreatmentCommunicable DiseasesInvestigationClinical Trials Unit
Grant awards (6)
Phase 1 Clinical Trial Units for Therapeutics Against Infectious Diseases: Evaluation of Therapeutics for Dengue Virus$1,472,261
N01 · FY2017 · AI · contact PI
Multi-Center Study to Evaluate the Efficacy and Safety of a Neisseria Gonorrhoeae Treatment Strategy$253,026
N01 · FY2016 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$217,157
N01 · FY2016 · AI · contact PI
Multi-Center Study to Evaluate the Efficacy and Safety of a Neisseria Gonorrhoeae Treatment Strategy$363,723
N01 · FY2015 · AI · contact PI
Phase I Clinical Trial Units$289,862
N01 · FY2015 · AI · contact PI
Sexually Transmitted Infections Clinical Trials Group$492,853
N02 · FY2014 · AI · contact PI